MedDataX Logo

CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?

NCT04014153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1023

Last updated 2019-10-29

No results posted yet for this study

Summary

Patients aged 18-89 with stable CAD and comorbidities receiving optimal medical treatment requiring PCI with iodinated contrast media.

The aim of the study is to assess the prevalence of contrast-induced AKI in 2012-2013 and 2017 cohorts and to evaluate the potential risk factors of CI-AKI to better guide the prevention in patients of higher risk.

Conditions

  • Stable Angina
  • Acute Kidney Injury
  • Contrast-induced Nephropathy

Interventions

PROCEDURE

Iodinated contrast media

Percutaneous coronary intervention with iodinated contest media

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-16
Primary Completion
2017-10-19
Completion
2018-12-12

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014153 on ClinicalTrials.gov